Gil Ben-Yakov
Overview
Explore the profile of Gil Ben-Yakov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ben-Yaacov A, Levine O, Schtrechman G, Adileh M, Beller T, Boursi B, et al.
World J Surg
. 2024 Apr;
48(4):871-878.
PMID: 38686748
Background: Colorectal peritoneal metastases are a devastating consequence of colorectal cancer (CRC) with extremely poor prognosis. Patients that can undergo complete cytoreduction by cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC)...
2.
Wright E, Kapuria D, Ben-Yakov G, Sharma D, Basu D, Cho M, et al.
Gastro Hep Adv
. 2023 Mar;
2(3):370-379.
PMID: 36938381
Background & Aims: Results of randomized clinical trials are often first presented as conference abstracts, but these abstracts may be difficult to find, and trial results included in the abstract...
3.
Velenosi T, Ben-Yakov G, Podszun M, Hercun J, Etzion O, Yang S, et al.
Gastroenterology
. 2022 Mar;
162(7):1990-2003.
PMID: 35283114
Background & Aims: Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We...
4.
Barron K, Aksentijevich I, Deuitch N, Stone D, Hoffmann P, Videgar-Laird R, et al.
Front Immunol
. 2022 Jan;
12:811473.
PMID: 35095905
The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited disease that has undergone extensive phenotypic expansion since being first described in patients with fevers, recurrent strokes, livedo...
5.
Kapuria D, Bollipo S, Rabiee A, Ben-Yakov G, Kumar G, Siau K, et al.
J Gastroenterol Hepatol
. 2020 Jul;
36(4):885-892.
PMID: 32656794
The global pandemic of coronavirus disease-2019 (COVID-19) has led to significant disruptions in healthcare delivery. Patients with chronic liver diseases require a high level of care and are therefore particularly...
6.
Bollipo S, Kapuria D, Rabiee A, Ben-Yakov G, Lui R, Lee H, et al.
Gut
. 2020 Jun;
69(8):1369-1372.
PMID: 32499304
No abstract available.
7.
Dizengof V, Levi I, Etzion O, Fich A, Blum A, Azulay Chertok I, et al.
Eur J Gastroenterol Hepatol
. 2020 Jan;
32(5):569-574.
PMID: 31895909
Background & Aims: After the rise of lymphoma incidence in the 1990's, there is a paucity of epidemiologic studies describing the characteristics of primary gastrointestinal non-Hodgkin's lymphoma (PGIL). This epidemiologic...
8.
Wright E, Kapuria D, Ben-Yakov G, Sharma D, Basu D, Cho M, et al.
JAMA Intern Med
. 2019 Sep;
179(12):1716-1717.
PMID: 31498399
No abstract available.
9.
Surana P, Kapuria D, Broadwell C, Wright E, Takyar V, Kleiner D, et al.
Antiviral Res
. 2019 May;
168:61-67.
PMID: 31125632
Background: Fibrosis regression has been associated with nucleoside analogue (NA) treatment in chronic hepatitis B (CHB) patients. Although non-invasive fibrosis markers have been evaluated in CHB, their utility for monitoring...
10.
Kapuria D, Ben-Yakov G, Ortolano R, Cho M, Kalchiem-Dekel O, Takyar V, et al.
Hepatology
. 2019 Feb;
69(6):2579-2585.
PMID: 30791107
Loss-of-function mutations in genes that encode for components of the telomere repair complex cause accelerated telomere shortening. Hepatic involvement has been recognized as a cause of morbidity in telomere diseases,...